RepliCel, Shiseido deal

RepliCel granted skincare company Shiseido exclusive rights to RCH-01 hair regeneration technology in Japan, China, South Korea, Taiwan and countries in the Association of Southeast Asian Nations (ASEAN). RepliCel will receive a ¥400 million ($3.9 million) upfront fee and is eligible for up to ¥3 billion ($29.4 million) in milestones, plus royalties. ...